A Phase 2a Multi-Center, Prospective, Randomized Controlled Study to Evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects With Diabetic Foot Ulcers (DFU)
Latest Information Update: 14 Oct 2025
At a glance
- Drugs Purified exosome product RION (Primary) ; Fibrin
- Indications Diabetic foot ulcer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Rion
Most Recent Events
- 01 Oct 2025 Planned End Date changed from 12 Sep 2025 to 12 Oct 2025.
- 01 Oct 2025 Planned primary completion date changed from 5 Sep 2025 to 5 Oct 2025.
- 22 Jul 2025 Planned End Date changed from 12 Jul 2025 to 12 Sep 2025.